Phase 2 trial results suggest retatrutide may offer a triple therapy option to address the multiple metabolic factors that affect people who are obese, regardless of type 2 diabetes status, said Arun J. Sanyal, MD. He and other investigators will share new data on this GIP/GLP-1/glucagon receptor triagonist and its effects on obesity, type 2…

Various self-assessment tools exist to help patients with diabetes monitor their daily activities and provide their care teams with insights into glucose levels. Methods for tracking behavioral markers include sleep monitoring and actigraphy devices to track physical activity. Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN, discussed ecological momentary assessments.

Dietary choices are crucial for managing type 2 diabetes. Experts including Roy Taylor, MD, shared their perspectives on nutrition programs that have helped patients reduce or manage type 2 diabetes while also living healthier lives. These programs incorporate low-calorie diets, low-carb diets, and glycemic excursion minimization.

As part of a panel in the ADA Diabetes Journal Symposium, Jonathan Z. Long, PhD, will discuss signaling pathways in energy metabolism, including exercise-induced mediators of body adiposity. He will also share cutting-edge research using a cell-type-specific proteomic approach.

Pathway to Stop Diabetes® researchers, including Aleksandar D. Kostic, PhD, presented their new approaches for working toward a cure for this pervasive disease. These investigators are looking at the gut microbiome, cloaked beta-cells, branched-chain amino acid, dysregulation of the gut-brain axis by sugar, and diabetes distress with new perspectives with funding from the American Diabetes…

Therapeutic inertia is a common problem in managing type 2 diabetes. Experts including Kevin M. Pantalone, DO, ECNU, FACE, addressed how it can be prevented, such as achieving A1C targets within a year of treatment, leveraging the entire health care team in the patient’s journey, and having accessibility to the patient’s electronic health record.

CGM technology has the potential for use as a preventative tool in diabetes and obesity, and researchers continue to learn more about the effects of CGM use in people living with diabetes who are treated with insulin and those who are not. Three experts, including Ronnie Aronson, MD, will discuss emerging evidence.

Some of the diabetes management tools with the greatest efficacy are those that patients can use by themselves. Experts including Sarah S. Jaser, PhD, will discuss the impact tracking blood glucose levels, sleep quality, diet choices, and other behaviors can have in disease management while paying tribute to behavioral diabetes pioneer Mark Peyrot, PhD.

Proper nutrition can help regulate diabetes. Christopher Gardner, PhD, will discuss the advantages of consuming a plant-based, whole-food diet, along with the health and global benefits of switching from animal protein to plant-based protein. Other presenters will discuss portion size and calorie density, and how processed foods impact energy balance.